Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatitis C, Chronic | 17 | 2021 | 1032 | 2.270 |
Why?
|
Hepatectomy | 12 | 2020 | 557 | 1.430 |
Why?
|
Liver Transplantation | 26 | 2021 | 2330 | 1.320 |
Why?
|
Hepatitis E | 3 | 2019 | 76 | 1.250 |
Why?
|
Antiviral Agents | 10 | 2021 | 3060 | 1.130 |
Why?
|
Liver Neoplasms | 22 | 2019 | 4320 | 1.060 |
Why?
|
Carcinoma, Hepatocellular | 18 | 2019 | 2298 | 1.050 |
Why?
|
Liver Cirrhosis | 13 | 2019 | 1935 | 0.940 |
Why?
|
Interferon-alpha | 7 | 2009 | 921 | 0.940 |
Why?
|
Ploidies | 1 | 2024 | 285 | 0.920 |
Why?
|
Penile Induration | 1 | 2022 | 16 | 0.820 |
Why?
|
Italy | 19 | 2019 | 842 | 0.820 |
Why?
|
Ribavirin | 5 | 2009 | 395 | 0.740 |
Why?
|
Bile Ducts | 4 | 2017 | 282 | 0.660 |
Why?
|
Gastrointestinal Stromal Tumors | 6 | 2020 | 617 | 0.620 |
Why?
|
Liver | 16 | 2021 | 7529 | 0.580 |
Why?
|
Foodborne Diseases | 1 | 2016 | 41 | 0.540 |
Why?
|
Cholelithiasis | 1 | 2017 | 407 | 0.530 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2017 | 232 | 0.510 |
Why?
|
Echinococcosis | 1 | 2015 | 31 | 0.510 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 2 | 2017 | 506 | 0.500 |
Why?
|
Cholestasis | 2 | 2017 | 378 | 0.490 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 4 | 2020 | 368 | 0.460 |
Why?
|
Fatty Liver | 9 | 2010 | 790 | 0.450 |
Why?
|
Insulin Resistance | 4 | 2022 | 3963 | 0.440 |
Why?
|
Hepatitis E virus | 3 | 2019 | 72 | 0.410 |
Why?
|
Acute Kidney Injury | 3 | 2019 | 1924 | 0.410 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2024 | 5305 | 0.400 |
Why?
|
Melanoma | 3 | 2024 | 5709 | 0.380 |
Why?
|
Polyethylene Glycols | 4 | 2009 | 1189 | 0.370 |
Why?
|
Gastrointestinal Neoplasms | 4 | 2019 | 954 | 0.370 |
Why?
|
Laparoscopy | 8 | 2020 | 2035 | 0.350 |
Why?
|
Toll-Like Receptors | 1 | 2013 | 589 | 0.330 |
Why?
|
B-Cell Activating Factor | 1 | 2009 | 115 | 0.320 |
Why?
|
Immunocompromised Host | 3 | 2019 | 856 | 0.310 |
Why?
|
Cholangiocarcinoma | 3 | 2020 | 552 | 0.300 |
Why?
|
Bile Duct Neoplasms | 3 | 2020 | 605 | 0.300 |
Why?
|
Hepacivirus | 4 | 2011 | 1336 | 0.300 |
Why?
|
Rheumatoid Factor | 1 | 2008 | 185 | 0.300 |
Why?
|
Tacrolimus | 2 | 2011 | 733 | 0.290 |
Why?
|
Neoplasms, Connective and Soft Tissue | 2 | 2018 | 34 | 0.290 |
Why?
|
Middle Aged | 66 | 2024 | 220895 | 0.280 |
Why?
|
Kidney Diseases, Cystic | 2 | 2015 | 183 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-kit | 3 | 2019 | 727 | 0.270 |
Why?
|
Male | 77 | 2024 | 360804 | 0.260 |
Why?
|
Recombinant Proteins | 8 | 2009 | 6534 | 0.260 |
Why?
|
Chondrosarcoma | 2 | 2018 | 296 | 0.250 |
Why?
|
Negative-Pressure Wound Therapy | 2 | 2018 | 156 | 0.240 |
Why?
|
Hemophilia A | 1 | 2008 | 360 | 0.240 |
Why?
|
Kidney Transplantation | 5 | 2018 | 4234 | 0.240 |
Why?
|
Hepatitis C | 5 | 2011 | 1584 | 0.240 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2008 | 629 | 0.240 |
Why?
|
Thyroid Diseases | 1 | 2008 | 386 | 0.240 |
Why?
|
Humans | 114 | 2024 | 761504 | 0.230 |
Why?
|
Female | 75 | 2024 | 392644 | 0.230 |
Why?
|
Interferons | 1 | 2007 | 706 | 0.220 |
Why?
|
Pancreatic Neoplasms | 5 | 2023 | 5368 | 0.220 |
Why?
|
Hypertension | 3 | 2022 | 8540 | 0.220 |
Why?
|
Blood Loss, Surgical | 4 | 2019 | 637 | 0.220 |
Why?
|
Spleen | 1 | 2009 | 2295 | 0.220 |
Why?
|
Eosinophilia | 1 | 2008 | 560 | 0.210 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2023 | 34 | 0.210 |
Why?
|
Robotics | 3 | 2019 | 819 | 0.210 |
Why?
|
Blood Component Removal | 1 | 2023 | 132 | 0.200 |
Why?
|
Adult | 48 | 2024 | 221177 | 0.200 |
Why?
|
Immunosuppressive Agents | 5 | 2021 | 4174 | 0.190 |
Why?
|
Renal Dialysis | 4 | 2019 | 1797 | 0.190 |
Why?
|
Genetic Heterogeneity | 1 | 2024 | 732 | 0.190 |
Why?
|
Cocaine-Related Disorders | 1 | 2024 | 461 | 0.180 |
Why?
|
Uveal Neoplasms | 1 | 2024 | 341 | 0.180 |
Why?
|
Benzenesulfonates | 2 | 2011 | 166 | 0.180 |
Why?
|
Pancreatectomy | 2 | 2018 | 811 | 0.180 |
Why?
|
NAD+ Nucleosidase | 1 | 2000 | 43 | 0.180 |
Why?
|
Retrospective Studies | 24 | 2023 | 80636 | 0.180 |
Why?
|
End Stage Liver Disease | 2 | 2017 | 352 | 0.170 |
Why?
|
Aged | 38 | 2024 | 169289 | 0.170 |
Why?
|
Receptors, Steroid | 2 | 2018 | 156 | 0.170 |
Why?
|
Receptors, Thyroid Hormone | 2 | 2018 | 199 | 0.170 |
Why?
|
Echinococcosis, Hepatic | 1 | 2019 | 24 | 0.170 |
Why?
|
Fibroblast Growth Factor 4 | 1 | 2019 | 28 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 12148 | 0.170 |
Why?
|
Exons | 3 | 2020 | 2391 | 0.170 |
Why?
|
Lipids | 1 | 2010 | 3341 | 0.160 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2023 | 1351 | 0.160 |
Why?
|
HELLP Syndrome | 1 | 2019 | 40 | 0.160 |
Why?
|
Surgery, Computer-Assisted | 2 | 2018 | 1007 | 0.160 |
Why?
|
Drug Therapy, Combination | 5 | 2016 | 6310 | 0.160 |
Why?
|
Treatment Outcome | 22 | 2019 | 64680 | 0.150 |
Why?
|
Immunoglobulin M | 2 | 2016 | 1527 | 0.150 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2018 | 64 | 0.150 |
Why?
|
Thrombocythemia, Essential | 1 | 2019 | 113 | 0.150 |
Why?
|
Hepatitis, Chronic | 2 | 2016 | 52 | 0.150 |
Why?
|
Genotype | 5 | 2019 | 12990 | 0.150 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2017 | 44 | 0.150 |
Why?
|
Gene Duplication | 1 | 2019 | 314 | 0.150 |
Why?
|
INDEL Mutation | 1 | 2019 | 266 | 0.150 |
Why?
|
Surgical Wound Infection | 2 | 2018 | 1527 | 0.150 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2018 | 181 | 0.150 |
Why?
|
Antigens, Differentiation | 1 | 2000 | 910 | 0.140 |
Why?
|
HSC70 Heat-Shock Proteins | 1 | 2017 | 49 | 0.140 |
Why?
|
Retroperitoneal Fibrosis | 1 | 2017 | 42 | 0.140 |
Why?
|
Transplants | 1 | 2019 | 206 | 0.140 |
Why?
|
Fibromatosis, Aggressive | 1 | 2018 | 126 | 0.140 |
Why?
|
Autoantibodies | 4 | 2012 | 2116 | 0.140 |
Why?
|
Mutant Proteins | 1 | 2019 | 491 | 0.140 |
Why?
|
Mucormycosis | 1 | 2018 | 103 | 0.140 |
Why?
|
Azacitidine | 1 | 2018 | 336 | 0.140 |
Why?
|
Length of Stay | 7 | 2019 | 6425 | 0.140 |
Why?
|
Abdominal Neoplasms | 1 | 2018 | 287 | 0.140 |
Why?
|
3' Untranslated Regions | 1 | 2019 | 519 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2019 | 8547 | 0.140 |
Why?
|
Stomach Diseases | 1 | 2018 | 134 | 0.140 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2018 | 218 | 0.140 |
Why?
|
Thrombophilia | 1 | 2019 | 305 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2018 | 3639 | 0.140 |
Why?
|
Hepatitis Antibodies | 1 | 2016 | 67 | 0.130 |
Why?
|
Biliary Fistula | 1 | 2016 | 37 | 0.130 |
Why?
|
Hydronephrosis | 1 | 2017 | 271 | 0.130 |
Why?
|
Mushroom Poisoning | 1 | 2015 | 5 | 0.130 |
Why?
|
Elasticity Imaging Techniques | 1 | 2021 | 392 | 0.130 |
Why?
|
Triglycerides | 2 | 2022 | 2461 | 0.130 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2016 | 322 | 0.130 |
Why?
|
Brachial Artery | 1 | 2017 | 366 | 0.130 |
Why?
|
Pilot Projects | 3 | 2022 | 8631 | 0.130 |
Why?
|
Postoperative Complications | 8 | 2019 | 15631 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 3 | 2023 | 1844 | 0.130 |
Why?
|
Hospital Departments | 1 | 2015 | 134 | 0.120 |
Why?
|
Luminescent Measurements | 1 | 2016 | 342 | 0.120 |
Why?
|
Wound Closure Techniques | 1 | 2016 | 87 | 0.120 |
Why?
|
Luciferases | 1 | 2016 | 714 | 0.120 |
Why?
|
Renal Veins | 1 | 2015 | 102 | 0.120 |
Why?
|
Aneurysm, False | 1 | 2017 | 255 | 0.120 |
Why?
|
Surgical Wound Dehiscence | 1 | 2016 | 213 | 0.120 |
Why?
|
Sjogren's Syndrome | 1 | 2016 | 237 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 318 | 0.120 |
Why?
|
Liver Cirrhosis, Biliary | 2 | 2012 | 108 | 0.120 |
Why?
|
Obesity, Morbid | 3 | 2013 | 1277 | 0.120 |
Why?
|
Mycophenolic Acid | 1 | 2016 | 348 | 0.110 |
Why?
|
Nephritis, Interstitial | 1 | 2015 | 155 | 0.110 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4915 | 0.110 |
Why?
|
Sequence Deletion | 1 | 2018 | 1494 | 0.110 |
Why?
|
HIV Infections | 6 | 2021 | 17351 | 0.110 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2017 | 292 | 0.110 |
Why?
|
Case-Control Studies | 7 | 2021 | 22176 | 0.110 |
Why?
|
Radiosurgery | 1 | 2023 | 1342 | 0.110 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5821 | 0.110 |
Why?
|
Hemostasis, Surgical | 1 | 2014 | 126 | 0.110 |
Why?
|
Renal Artery | 1 | 2015 | 351 | 0.110 |
Why?
|
Severity of Illness Index | 7 | 2019 | 15842 | 0.110 |
Why?
|
beta Catenin | 1 | 2018 | 1040 | 0.110 |
Why?
|
Postoperative Period | 2 | 2015 | 1813 | 0.110 |
Why?
|
Viral Load | 4 | 2021 | 3332 | 0.110 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2020 | 0.110 |
Why?
|
Graft Survival | 3 | 2019 | 3819 | 0.110 |
Why?
|
Plant Extracts | 1 | 2016 | 498 | 0.110 |
Why?
|
Colonic Diseases, Functional | 1 | 1992 | 39 | 0.100 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2017 | 592 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2021 | 4580 | 0.100 |
Why?
|
Genomics | 3 | 2024 | 5821 | 0.100 |
Why?
|
Tranquilizing Agents | 1 | 1992 | 58 | 0.100 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2016 | 517 | 0.100 |
Why?
|
Abdomen | 2 | 2016 | 1128 | 0.100 |
Why?
|
Toll-Like Receptor 3 | 1 | 2013 | 98 | 0.100 |
Why?
|
Kidney Diseases | 1 | 2023 | 2091 | 0.100 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 613 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2018 | 1606 | 0.100 |
Why?
|
Ultrasonography, Interventional | 2 | 2018 | 1496 | 0.100 |
Why?
|
Endocrine System | 1 | 2013 | 114 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2019 | 2571 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 641 | 0.100 |
Why?
|
Risk Management | 1 | 2015 | 558 | 0.100 |
Why?
|
Catheter Ablation | 3 | 2017 | 2751 | 0.100 |
Why?
|
Aneurysm | 1 | 2015 | 337 | 0.100 |
Why?
|
Nephrology | 1 | 2015 | 263 | 0.100 |
Why?
|
Mutation | 5 | 2020 | 30052 | 0.100 |
Why?
|
Arteriovenous Fistula | 1 | 2015 | 319 | 0.100 |
Why?
|
Diazepam | 1 | 1992 | 215 | 0.100 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 2020 | 0.100 |
Why?
|
Toll-Like Receptor 7 | 1 | 2013 | 177 | 0.100 |
Why?
|
Carcinoma, Papillary | 1 | 2016 | 785 | 0.090 |
Why?
|
Tissue and Organ Procurement | 1 | 2019 | 961 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4111 | 0.090 |
Why?
|
Incidental Findings | 1 | 2016 | 697 | 0.090 |
Why?
|
Patient Selection | 3 | 2018 | 4244 | 0.090 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2011 | 100 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1136 | 0.090 |
Why?
|
Portal Vein | 1 | 2013 | 431 | 0.090 |
Why?
|
Toll-Like Receptor 2 | 1 | 2013 | 347 | 0.090 |
Why?
|
Hemostatic Techniques | 1 | 2011 | 112 | 0.090 |
Why?
|
Uridine Diphosphate Galactose | 1 | 1990 | 21 | 0.090 |
Why?
|
Biosensing Techniques | 1 | 2016 | 650 | 0.090 |
Why?
|
Biliary Tract Diseases | 1 | 2011 | 159 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4346 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 2 | 2024 | 5671 | 0.090 |
Why?
|
Antigens, CD | 1 | 2000 | 4003 | 0.090 |
Why?
|
Pancreatic Ducts | 1 | 2011 | 329 | 0.080 |
Why?
|
Databases, Factual | 3 | 2018 | 7967 | 0.080 |
Why?
|
Sirolimus | 3 | 2011 | 1533 | 0.080 |
Why?
|
Interferon Type I | 1 | 1993 | 562 | 0.080 |
Why?
|
Vascular Neoplasms | 1 | 2011 | 166 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2020 | 58976 | 0.080 |
Why?
|
Pyridines | 2 | 2011 | 2875 | 0.080 |
Why?
|
Splenic Artery | 1 | 2009 | 57 | 0.080 |
Why?
|
Alcoholism | 2 | 2018 | 1973 | 0.080 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 1990 | 190 | 0.080 |
Why?
|
Risk Factors | 10 | 2019 | 74206 | 0.080 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 26125 | 0.080 |
Why?
|
beta 2-Microglobulin | 1 | 2009 | 329 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2009 | 4853 | 0.080 |
Why?
|
Depression | 1 | 2008 | 8124 | 0.080 |
Why?
|
Vena Cava, Inferior | 1 | 2011 | 458 | 0.080 |
Why?
|
Microsomes | 1 | 2008 | 251 | 0.080 |
Why?
|
Hepatitis C Antigens | 1 | 2007 | 34 | 0.070 |
Why?
|
Liver Diseases, Alcoholic | 1 | 1990 | 156 | 0.070 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2008 | 94 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2018 | 2898 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2023 | 9280 | 0.070 |
Why?
|
Alanine Transaminase | 5 | 2010 | 603 | 0.070 |
Why?
|
Prognosis | 8 | 2023 | 29625 | 0.070 |
Why?
|
Ultrasonography, Doppler | 1 | 2009 | 462 | 0.070 |
Why?
|
Leiomyosarcoma | 1 | 2011 | 422 | 0.070 |
Why?
|
Obesity | 3 | 2008 | 12947 | 0.070 |
Why?
|
Base Sequence | 1 | 2018 | 12441 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1809 | 0.070 |
Why?
|
Young Adult | 7 | 2019 | 59243 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2018 | 1896 | 0.070 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10194 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13255 | 0.070 |
Why?
|
Vascular Resistance | 1 | 2009 | 930 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3617 | 0.070 |
Why?
|
Plasma Cells | 1 | 2010 | 599 | 0.070 |
Why?
|
Survival Rate | 5 | 2023 | 12725 | 0.070 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 1459 | 0.070 |
Why?
|
Polycystic Kidney, Autosomal Recessive | 1 | 2005 | 31 | 0.060 |
Why?
|
Hepatomegaly | 1 | 2005 | 84 | 0.060 |
Why?
|
MicroRNAs | 2 | 2019 | 3816 | 0.060 |
Why?
|
RNA, Viral | 3 | 2011 | 2846 | 0.060 |
Why?
|
Thrombosis | 1 | 2019 | 2942 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 1727 | 0.060 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39106 | 0.060 |
Why?
|
Thyroid Hormones | 1 | 2008 | 404 | 0.060 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2005 | 75 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3802 | 0.060 |
Why?
|
Splenomegaly | 1 | 2005 | 189 | 0.060 |
Why?
|
Pancytopenia | 1 | 2005 | 102 | 0.060 |
Why?
|
Transaminases | 1 | 2005 | 198 | 0.060 |
Why?
|
Transglutaminases | 1 | 2005 | 197 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4511 | 0.060 |
Why?
|
Organ Size | 1 | 2009 | 2254 | 0.060 |
Why?
|
Chemoembolization, Therapeutic | 2 | 2017 | 128 | 0.060 |
Why?
|
Ion Channels | 1 | 2009 | 1040 | 0.060 |
Why?
|
Venous Thrombosis | 1 | 2013 | 1303 | 0.060 |
Why?
|
Ultrasonography | 2 | 2015 | 5972 | 0.060 |
Why?
|
Uremia | 1 | 2004 | 201 | 0.050 |
Why?
|
Extracellular Fluid | 1 | 2004 | 165 | 0.050 |
Why?
|
Hospitals, University | 2 | 2018 | 563 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2018 | 9606 | 0.050 |
Why?
|
Rhabdomyolysis | 1 | 2024 | 152 | 0.050 |
Why?
|
Adiponectin | 1 | 2009 | 1113 | 0.050 |
Why?
|
Mitochondrial Proteins | 1 | 2009 | 976 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 54425 | 0.050 |
Why?
|
Eosinophils | 1 | 2008 | 950 | 0.050 |
Why?
|
Bariatric Surgery | 1 | 2013 | 992 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2019 | 6814 | 0.050 |
Why?
|
Niacinamide | 2 | 2017 | 413 | 0.050 |
Why?
|
Ferritins | 1 | 2005 | 598 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2019 | 12795 | 0.050 |
Why?
|
Time Factors | 6 | 2018 | 39967 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6484 | 0.050 |
Why?
|
Peritonitis | 1 | 2004 | 368 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 6 | 2017 | 20570 | 0.050 |
Why?
|
Phenylurea Compounds | 2 | 2017 | 529 | 0.050 |
Why?
|
Hemodialysis Units, Hospital | 1 | 2000 | 22 | 0.050 |
Why?
|
GTP-Binding Proteins | 1 | 2005 | 951 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15936 | 0.050 |
Why?
|
Adolescent | 8 | 2019 | 88319 | 0.050 |
Why?
|
ADP-ribosyl Cyclase | 1 | 2000 | 38 | 0.050 |
Why?
|
Leptin | 1 | 2009 | 1597 | 0.050 |
Why?
|
CD4 Lymphocyte Count | 2 | 2021 | 2571 | 0.040 |
Why?
|
Aspartate Aminotransferases | 3 | 2009 | 416 | 0.040 |
Why?
|
Herpesviridae Infections | 1 | 2002 | 270 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2016 | 3613 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2010 | 4544 | 0.040 |
Why?
|
Aminopyridines | 1 | 2024 | 573 | 0.040 |
Why?
|
Liver Diseases | 2 | 2005 | 1298 | 0.040 |
Why?
|
Binding Sites | 2 | 2019 | 6055 | 0.040 |
Why?
|
Recurrence | 3 | 2019 | 8465 | 0.040 |
Why?
|
Neoadjuvant Therapy | 1 | 2011 | 2827 | 0.040 |
Why?
|
Stents | 1 | 2011 | 3179 | 0.040 |
Why?
|
Fibroblast Growth Factor 3 | 1 | 2019 | 17 | 0.040 |
Why?
|
Warm Ischemia | 1 | 2019 | 58 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7048 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2023 | 1341 | 0.040 |
Why?
|
gamma-Glutamyltransferase | 2 | 2010 | 144 | 0.040 |
Why?
|
Complement Inactivating Agents | 1 | 2019 | 53 | 0.040 |
Why?
|
Mitochondria | 1 | 2012 | 3624 | 0.040 |
Why?
|
Calreticulin | 1 | 2019 | 114 | 0.040 |
Why?
|
Succinate Dehydrogenase | 1 | 2019 | 145 | 0.040 |
Why?
|
Energy Intake | 1 | 2006 | 2134 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2020 | 9420 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2007 | 1171 | 0.040 |
Why?
|
Receptors, Thrombopoietin | 1 | 2019 | 160 | 0.040 |
Why?
|
Electron Transport Complex II | 1 | 2018 | 53 | 0.040 |
Why?
|
Liver Function Tests | 2 | 2011 | 523 | 0.040 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2019 | 410 | 0.040 |
Why?
|
Anastomosis, Surgical | 2 | 2011 | 983 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 257 | 0.040 |
Why?
|
Amphotericin B | 1 | 2018 | 142 | 0.040 |
Why?
|
Pyrroles | 1 | 2024 | 1125 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2008 | 6019 | 0.040 |
Why?
|
Venous Thromboembolism | 1 | 2011 | 1866 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2010 | 2244 | 0.040 |
Why?
|
Celiac Disease | 1 | 2005 | 821 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12690 | 0.040 |
Why?
|
Learning Curve | 1 | 2019 | 230 | 0.040 |
Why?
|
Equipment Design | 2 | 2016 | 3510 | 0.040 |
Why?
|
Vitis | 1 | 2016 | 19 | 0.040 |
Why?
|
Cholangitis | 2 | 2010 | 111 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2018 | 2917 | 0.030 |
Why?
|
Groin | 1 | 2017 | 106 | 0.030 |
Why?
|
Retroperitoneal Space | 1 | 2017 | 170 | 0.030 |
Why?
|
RNA-Binding Protein EWS | 1 | 2018 | 210 | 0.030 |
Why?
|
Peptostreptococcus | 1 | 1996 | 29 | 0.030 |
Why?
|
Child, Preschool | 2 | 2016 | 42230 | 0.030 |
Why?
|
Immune System Diseases | 1 | 2019 | 256 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20098 | 0.030 |
Why?
|
Neoplasms | 2 | 2023 | 22170 | 0.030 |
Why?
|
Organotechnetium Compounds | 1 | 1996 | 129 | 0.030 |
Why?
|
Pancreas | 1 | 2023 | 1691 | 0.030 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2000 | 328 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2019 | 560 | 0.030 |
Why?
|
Cohort Studies | 4 | 2018 | 41487 | 0.030 |
Why?
|
Liver Abscess | 1 | 1996 | 81 | 0.030 |
Why?
|
Protein Stability | 1 | 2018 | 578 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10766 | 0.030 |
Why?
|
Amanita | 1 | 2015 | 2 | 0.030 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13639 | 0.030 |
Why?
|
Limit of Detection | 1 | 2016 | 273 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2023 | 11121 | 0.030 |
Why?
|
Risk Assessment | 4 | 2019 | 23995 | 0.030 |
Why?
|
Laparoscopes | 1 | 2015 | 37 | 0.030 |
Why?
|
Gallium Radioisotopes | 1 | 1996 | 195 | 0.030 |
Why?
|
Microwaves | 1 | 2017 | 185 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2008 | 3728 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2011 | 15266 | 0.030 |
Why?
|
Oximes | 1 | 1996 | 303 | 0.030 |
Why?
|
Karyotyping | 1 | 2016 | 1171 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1092 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1827 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2007 | 4758 | 0.030 |
Why?
|
Constriction | 1 | 2014 | 168 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2200 | 0.030 |
Why?
|
ras Proteins | 1 | 2019 | 1054 | 0.030 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 1996 | 343 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2626 | 0.030 |
Why?
|
Antifungal Agents | 1 | 2018 | 752 | 0.030 |
Why?
|
Receptors, Notch | 1 | 2017 | 743 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12059 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11742 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2016 | 1529 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 858 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2023 | 5869 | 0.030 |
Why?
|
Patient Positioning | 1 | 2015 | 326 | 0.030 |
Why?
|
Triazoles | 1 | 2018 | 903 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2019 | 10445 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2011 | 1897 | 0.030 |
Why?
|
Prevalence | 3 | 2011 | 15732 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3162 | 0.030 |
Why?
|
Drug Evaluation | 1 | 1993 | 641 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1787 | 0.020 |
Why?
|
Postpartum Period | 1 | 2019 | 1173 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 3416 | 0.020 |
Why?
|
Biopsy | 3 | 2010 | 6766 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2011 | 6935 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 938 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6132 | 0.020 |
Why?
|
Child | 2 | 2016 | 80153 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2016 | 1784 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2009 | 2850 | 0.020 |
Why?
|
Protein Conformation | 1 | 2019 | 3968 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2510 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2016 | 933 | 0.020 |
Why?
|
Gene Deletion | 1 | 2018 | 2665 | 0.020 |
Why?
|
Portacaval Shunt, Surgical | 1 | 2010 | 46 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2396 | 0.020 |
Why?
|
Ethanol | 1 | 2017 | 1324 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3602 | 0.020 |
Why?
|
Preoperative Care | 1 | 2019 | 2242 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2011 | 573 | 0.020 |
Why?
|
HIV-1 | 2 | 2021 | 6863 | 0.020 |
Why?
|
Hepatic Veins | 1 | 2010 | 112 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2000 | 3702 | 0.020 |
Why?
|
Piperidines | 1 | 2018 | 1656 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1745 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18395 | 0.020 |
Why?
|
Liver Failure | 1 | 2011 | 250 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5439 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2011 | 957 | 0.020 |
Why?
|
Cyclosporine | 1 | 2011 | 778 | 0.020 |
Why?
|
Drug Substitution | 1 | 2011 | 290 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4369 | 0.020 |
Why?
|
Vascular Patency | 1 | 2011 | 911 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3514 | 0.020 |
Why?
|
Cholangitis, Sclerosing | 1 | 2010 | 177 | 0.020 |
Why?
|
Diet | 1 | 2006 | 8075 | 0.020 |
Why?
|
Hypertension, Portal | 1 | 2010 | 226 | 0.020 |
Why?
|
Hepatitis, Autoimmune | 1 | 2010 | 172 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2011 | 1096 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4278 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2016 | 1589 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3877 | 0.020 |
Why?
|
Patient Care Team | 1 | 2018 | 2521 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2010 | 864 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1999 | 2155 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3518 | 0.020 |
Why?
|
Budd-Chiari Syndrome | 1 | 1985 | 24 | 0.020 |
Why?
|
Duodenoscopy | 1 | 2005 | 45 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7396 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3712 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9351 | 0.020 |
Why?
|
Reoperation | 1 | 2016 | 4303 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6240 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10090 | 0.020 |
Why?
|
Postoperative Care | 1 | 2011 | 1468 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2011 | 809 | 0.020 |
Why?
|
Disease Progression | 2 | 2016 | 13506 | 0.020 |
Why?
|
Antibiotic Prophylaxis | 1 | 2010 | 636 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8529 | 0.020 |
Why?
|
HIV | 1 | 2011 | 1582 | 0.010 |
Why?
|
Sex Factors | 2 | 2010 | 10552 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12463 | 0.010 |
Why?
|
Neutrophils | 1 | 1996 | 3767 | 0.010 |
Why?
|
Models, Biological | 1 | 2019 | 9469 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9486 | 0.010 |
Why?
|
Duodenum | 1 | 2005 | 490 | 0.010 |
Why?
|
Ascites | 1 | 2004 | 338 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2018 | 3408 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2005 | 978 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16981 | 0.010 |
Why?
|
Weight Loss | 1 | 2013 | 2684 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21353 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12974 | 0.010 |
Why?
|
Electric Impedance | 1 | 2004 | 757 | 0.010 |
Why?
|
Cholesterol | 1 | 2009 | 2904 | 0.010 |
Why?
|
Hepatitis B | 1 | 2004 | 705 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2005 | 1315 | 0.010 |
Why?
|
Contrast Media | 1 | 2011 | 5311 | 0.010 |
Why?
|
Graft Rejection | 1 | 2011 | 4445 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 29874 | 0.010 |
Why?
|
Technetium Tc 99m Exametazime | 1 | 1996 | 61 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 14031 | 0.010 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2002 | 612 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 2002 | 831 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2011 | 4527 | 0.010 |
Why?
|
Blood Glucose | 1 | 2009 | 6391 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5840 | 0.010 |
Why?
|
Insulin | 1 | 2009 | 6596 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23445 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1996 | 1972 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81525 | 0.010 |
Why?
|
United States | 1 | 2018 | 72334 | 0.010 |
Why?
|
Mass Screening | 1 | 2005 | 5428 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2004 | 3415 | 0.010 |
Why?
|
Body Mass Index | 1 | 2005 | 12953 | 0.000 |
Why?
|
Animals | 1 | 2018 | 168459 | 0.000 |
Why?
|
Colitis, Ulcerative | 1 | 1976 | 1922 | 0.000 |
Why?
|
Crohn Disease | 1 | 1976 | 2279 | 0.000 |
Why?
|
Megacolon | 1 | 1976 | 11 | 0.000 |
Why?
|
Intestinal Polyps | 1 | 1976 | 104 | 0.000 |
Why?
|
Thrombophlebitis | 1 | 1976 | 289 | 0.000 |
Why?
|
Intestinal Fistula | 1 | 1976 | 142 | 0.000 |
Why?
|
Intestinal Neoplasms | 1 | 1976 | 312 | 0.000 |
Why?
|
Radiography | 1 | 1976 | 6965 | 0.000 |
Why?
|